|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
20 June 2023 |
|
Main ID: |
NCT02840656 |
|
Date of registration:
|
19/07/2016 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization
OroColi-HS |
|
Scientific title:
|
Comparative Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization of Healthy Adults Subjects |
|
Date of first enrolment:
|
September 2016 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02840656 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Jonathan MESSIKA, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hopital Louis Mourier - Assistance Publique Hopitaux de Paris |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- age > 18 yo
- personal history of neck or face irradiation
- no history of gastrointestinal disease
- no symptoms of immunosuppression
- no antibiotic therapy in the previous month
- no hospitalization in the 3 months preceding inclusion
- medical exmination prior to inclusion
Exclusion Criteria:
- affiliated to the social security
- The refusal of a patient to participate in a study
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Oropharyngeal Gram-negative Bacilli Colonization
|
|
Intervention(s)
|
|
Other: rectal swabbing
|
|
Other: oropharyngeal swabbing
|
|
Primary Outcome(s)
|
|
proportion of patients with an oropharyngeal gram-negative colonization
[Time Frame: Day 1]
|
|
Secondary Outcome(s)
|
|
incidence of the a GNB oropharyngeal colonization
[Time Frame: Day 1]
|
|
phylogenetic and virulence factor content of E. coli oropharyngeal and rectal colonization
[Time Frame: Day 1]
|
|
characterization of antimicrobial and chlorhexidine susceptibility of Gram negative bacteria from oropharyngeal colonization
[Time Frame: Day 1]
|
|
comparision of the predominant fecal flora with GNB oropharyngeal colonization
[Time Frame: Day 1]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|